FCSRX | HBLYX | FCSRX / HBLYX | |
Total Expense Ratio | 1.70 | 0.67 | 254% |
Annual Report Gross Expense Ratio | 1.77 | 0.67 | 264% |
Fund Existence | 20 years | 19 years | - |
Gain YTD | 4.841 | 6.420 | 75% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250000 | - |
Min. Initial Investment IRA | 500 | N/A | - |
Net Assets | 493M | 11.9B | 4% |
Annual Yield % from dividends | 3.73 | 3.51 | 106% |
Returns for 1 year | 6.60 | 5.10 | 129% |
Returns for 3 years | 11.94 | 15.15 | 79% |
Returns for 5 years | 35.39 | 16.20 | 219% |
Returns for 10 years | 32.13 | 44.89 | 72% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HQL | 13.38 | 0.05 | +0.38% |
abrdn Life Sciences Investors | |||
VCRM | 72.98 | 0.19 | +0.26% |
Vanguard Core Tax-Exempt Bond ETF | |||
VEGN | 56.92 | 0.10 | +0.18% |
US Vegan Climate ETF | |||
QTOC | 32.50 | 0.03 | +0.10% |
Innovator Growth Accelertd Pls ETF™ Oct | |||
AAXJ | 85.48 | -0.23 | -0.27% |
iShares MSCI All Country Asia ex Jpn ETF |